Founding Director, Massachusetts Technology Transfer Center
Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
Vice president, chief strategy and operating officer of the Texas Medical Center
Founder and CEO, Lighter Capital
Following a highly successful presentation during the recent BIO International Convention, Campbell Alliance is scheduled to present the results of its fourth annual “dealmakers’ intentions survey,” the only forward-looking measure of deal-making activity in the pharmaceutical and biotech industries. In addition to Campbell’s prospective view of the partnering and licensing landscape, Campbell Vice President Jeff Liepman will moderate a deals discussion with executives from Cadence Pharmaceuticals, Halozyme Therapeutics, Ambit Biosciences, Receptos, and Tracon Pharmaceuticals. More information and online registration is here.